STRK: 18,750 Options Exercised; 18,750 Shares Sold on Aug 7
Andrew Kang, listed as EVP & CFO, reported exercising 18,750 Class A common shares on 08/07/2025 under an employee stock option with a conversion/exercise price of $19.744.
Rhea-AI Filing Summary
Andrew Kang, listed as EVP & CFO, reported exercising 18,750 Class A common shares on 08/07/2025 under an employee stock option with a conversion/exercise price of $19.744. The filing states those 18,750 shares vested on 05/18/2024.
On the same date he reported three sales of 6,250 shares each at $390, $395 and $400. After these transactions the filing shows direct beneficial ownership of Class A common stock of 24,460 shares. The option cited has 87,500 remaining shares subject to it with vesting: 12,500 vested 05/18/2024, 37,500 vested 05/18/2025, and 37,500 scheduled to vest 05/18/2026.
Positive
- Exercise of 18,750 option shares at a stated conversion price of $19.744
- Three reported sales of 6,250 shares each at $390, $395, and $400—all explicitly disclosed
- Remaining option holdings quantified: 87,500 shares subject to the option with specific vesting dates
Negative
- Direct holdings reduced to 24,460 Class A shares after the reported sales
- Substantial disposition of 18,750 shares on a single day by an executive, which may reduce insider share exposure
Insights
TL;DR: EVP exercised 18,750 options at $19.744 and immediately sold the same number of shares in three tranches at $390–$400.
The filing shows a routine insider exercise-and-sale on 08/07/2025: an in-the-money option exercise at a $19.744 strike followed by three block sales of 6,250 shares each at $390, $395, and $400. The transactions reduced direct holdings to 24,460 shares while leaving 87,500 option shares outstanding on a defined vesting schedule. For investors, this is a liquidity event by management rather than a corporate action; it signals option monetization but does not, by itself, change company capital structure.
TL;DR: Insider disclosure is complete and includes vesting schedule; transactions appear documented and signed by attorney-in-fact.
The Form 4 details exercised options, corresponding sales, and a clear vesting timeline: vested tranches on 05/18/2024 and 05/18/2025, with remaining vesting on 05/18/2026. The signature block shows filing was executed by an attorney-in-fact on 08/11/2025. From a governance perspective, the filing meets Section 16 transparency expectations by reporting both acquisition and disposition amounts and the remaining derivative position.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 18,750 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 18,750 | $19.744 | $370K |
| Sale | Class A Common Stock | 6,250 | $390.00 | $2.44M |
| Sale | Class A Common Stock | 6,250 | $395.00 | $2.47M |
| Sale | Class A Common Stock | 6,250 | $400.00 | $2.50M |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
Footnotes (1)
- F1. The 18,750 shares exercised on August 7, 2025 pursuant to this option vested on May 18, 2024. Of the remaining 87,500 shares subject to this option, 12,500 shares vested on May 18, 2024, 37,500 shares vested on May 18, 2025, and 37,500 shares are scheduled to vest on May 18, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 4 disclose for STRK on 08/07/2025?
What is Andrew Kang's direct beneficial ownership after the transactions?
Who signed or filed the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.
